Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pulmonary Embolism & DVT Introduction • • • • • • • Pathophysiology Risk Factors Symptoms Lab Findings Radiology Findings Treatment Prevention Pathophysiology Dislodgement of a blood clot: • • • • • Lower Extremities: 65% to 90% Pelvic venous system Renal venous system Upper Extremity Right Heart Risk Factors for PE and DVT • Immobilization • Surgery within the last 3 months • Stroke • History of venous thromboembolism • Malignancy • Preexisting respiratory disease • Chronic Heart Disease • Age >60 • Surgery requiring >30mins of anesthesia • Recent travel (past 2weeks, >4 hours) • Varicose veins • Superficial vein thrombosis • Central VV catheter/port/pacemaker Additional RF in Women: • Obesity BMI >/=29 • Heavy smoking (>25cigs/day) • Hypertension • Pregnancy Well’s Criteria Clinical Signs and Symptoms of DVT? +3 (Calf tenderness, swelling >3cm, errythema, pitting edema affected leg only) PE Is #1 Diagnosis, or Equally Likely +3 Heart Rate > 100 +1.5 Immobilization at least 3 days, or Surgery in the Previous 4 weeks +1.5 Previous, objectively diagnosed PE or DVT? +1.5 Hemoptysis +1 Malignancy w/ Rx within 6 mo, or palliative? +1 >6: 2 to 6: 2 or less: High Risk Moderate Risk Low Adapted with permission from Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED d-dimer. Thromb Haemost 2000;83:416-20. P.E. and Malignancy • A Presenting sign in: – Pancreatic cancer – Prostate cancer • Late sign in: – – – – Breast cancer Lung cancer Uterine cancer Brain cancer Symptoms of P.E. • • • • Dyspnea Pleuritic pain Cough Hemoptysis (blood tinged/streaked/ pure blood) Signs of P.E. • • • • • • • Tachypnea Rales Tachycardia Hypoxia S4 Accentuated pulmonic component of S2 Fever: T <102 F Signs in Massive P.E. • “Massive PE”: hemodynamic instability with SBP <90 or a drop in baseline SBP by >/=40mmHg • Signs as before PLUS: – Acute right heart failure • Elevated J.V.P. • Right-sided S3 • Parasternal lift P.E. & Leg Symptoms • Most patients with P.E. do not have leg symptoms at time of diagnosis • Patients with leg symptoms may have asymptomatic P.E. Lab & Radiologic Findings in P.E. • • • • • • • • • ABG BNP Cardiac Enzymes: Troponin D-dimer EKG CXR Ultrasound V/Q Scan Angiography Lab Findings in P.E. (ABG) • ABG: – – – – Hypoxemia Hypocapnia (low CO2) Respiratory Alkalosis Massive PE: hypercapnia, mix resp and metabolic acidosis (inc lactic acid) – Patients with RA pulse ox readings <95% are at increased risk of in-hospital complications, resp failure, cardiogenic shock, death Lab Findings in P.E. (BNP) • BNP (beta natruretic peptide) – Insensitive test – Patient’s with PE have higher levels than pts without, but not ALL patients with PE have high BNP – Good prognostic value measure: if BNP >90 associated with adverse clinical outcomes (death, CPR, mechanical vent, pressure support, thrombolysis, embolectomy) Lab Findings in P.E. (Troponin) • Troponin – High in 30-50% of pts with mod to large PE – Prognostic value if combined pro-NT BNP • Trop I >0.07 + NT-proBNP >600 = high 40 day mortality Lab Findings in P.E. (D-dimer) • D-dimer: – Degredation product of fibrin – >500 is abnormal – Sensitivity: High, 95% of PE pts will be positive – Specificity: Low – Negative Predictive Value: Excellent S1Q3T3!!! RAD Right Atrial Enlargement Lab Findings in P.E. (cont’d) • EKG – 2 Most Common finding on EKG: • Nonspecific ST-segment and T-wave changes • Sinus Tachycardia – Historical abnormality suggestive of PE • S1Q3T3 • Right ventricular strain • New incomplete RBBB Radiologic Findings in P.E. GOLD STANDARD IN DIAGNOSING PULMONARY EMBOLISM? PULMONARY ANGIOGRAM Radiology Findings in P.E. (cont’d) • CXR: – Normal – Atelectasis and/or pulmonary parenchymal abnormality – Pleural Effusion – Cardiomegally What’s This??? Hampton’s Hump How About This??? Westermark's Sign: an abrupt tapering of a vessel caused by pulmonary thromboembolic obstruction. This CXR shows enlargement of the left hilum accompanied by left lung hyperlucency, indicating oligemia (Westermark's sign). Radiology Findings in P.E. (cont’d) V/Q Scan: • Results: High, Intermediate, Low Probability • Best if combined with Clinical Probability (PIOPED study): – High Clinical Prob + High Prob VQ= 95% likelihood of having a P.E. – Low Clinical Prob + Low Prob VQ= 4% likelihood of having a P.E. Radiology Findings in P.E. (cont’d) Lower Extremity Ultrasounds • If DVT found then treatment is same if patient has a P.E. • Disadvantage: – If negative, patients with PE may be missed – If false positive (3%), unnecessary intervention Radiology Findings in P.E. (cont’d) • • • • CT Pulmonary Angiography (CT-PA) Widely used Institution dependent Sensitivity (83%) Specificity (96%): if negative, very low likelihood that pt has P.E. Radiology Findings in P.E. (cont’d) Pulmonary Angiogram • Gold Standard • Not easily accessible • Radiologist dependent Radiology Findings in P.E. (cont’d) Echocardiogram • Increased Right Ventricle Size • Decreased Right Ventricular Function • Tricuspid Regurgitation Rarely: • RV thrombus • Regional wall motion abnormalities that spare the right ventricle apex (McConnell’s Sign) Hypercoagulability Work Up • No consensus on who to test • Increased likelihood if: – Age <50y/o without immediate identifiable risk factors (idiopathic or provoked) – Family history – Recurrent clots – If clot is in an unusual site (portal, hepatic, mesenteric, cerebral) – Unprovoked upper extremity clot (no catheter, no surgeries) – Patient’s with warfarin induced skin necrosis (they may have protein C deficiency Hypercoagulability Work Up – – – – – – Protein C/S deficiency Factor V leiden deficiency AntiThrombin III deficiency Prothrombin 20210 mutation Antiphospholipid antibody High Homocysteine Most Common Cause of Congenital Hypercoagulablity • Protein C resistance d/t Factor V leiden mutation Treatment of P.E. • Respiratory Support: Oxygen, intubation • Hemodynamic Support: IVF, vasopressors • Anticoagulation • Thrombolysis • IVC Filter Anticoagulation • Start during resuscitation phase itself • If suspicion high, start emperic anticoagulation • Evaluate patient for absolute contraindication (i.e.: active bleeding) Anticoagulation (cont’d) • HEPARIN: – Lovenox: if hemodynamically stable, no renal function • 1mg/kg BID OR 1.5mg/kg QDay – Heparin gtt: if hypotension, renal failure • 80units/kg bolus then 18units/kg infusion • Goal PTT1.5 to 2.5 times the upper limit of normal • COUMADIN: – Start once acute anticoagulation achieved – Start with 5mg PO qday OR 10mg PO q day – If start with 10mg then achieve therapeutic INR 1.4 days sooner – Complications and morbidity no different in 5mg or 10mg start – Goal INR 2 to 3 Duration of Anticoagulation for DVT or PE* Event Duration Strength of Recommendation First Time event of Reversible cause (surgery/trauma) At least 3 mos A First episode of idiopathic VTE At least 6 mos A Recurrent idiopathic VTE or continuing risk factor (e.g., thrombophilia, cancer) At least 12 mos B Symptomatic isolated calf-vein thrombosis 6 to 12 weeks A *From American College of Chest Physicians Thrombolysis • Considered once P.E. diagnosed • If chosen, hold anticoagulation during thrombolysis infusion, then resumed • Associated with higher incidence of major hemorrhage • Indications: persistent hypotension, severe hypoxemia, large perfusion defecs, right ventricular dysfunction, free floating right ventricular thrombus, paten foramen ovale • Activase or streptokinase IVC Filter • Indication: – Absolute contraindication to anticoagulation (i.e. active bleeding) – Recurrent PE during adequate anticoagulation – Complication of anticoagulation (severe bleeding) • Also: – – – – Pts with poor cardiopulmonary reserve Recurrent P.E. will be fatal Patient’s who have had embolectomy Prophylaxis against P.E. in select patients (malignancy) Embolectomy • Surgical or catheter • Indication: – Those who present severe enough to warrant thrombolysis – In those where thrombolysis is contraindicated or fails Questions?